A: At InjectCo, tirzepatide is administered by experienced nurse injectors under medical director supervision, ensuring safety, precision, and consistent patient care
Standard titration protocol from clinical trials The Phase 2 NEJM trial used the following escalation schedule for the 12 mg dose group: Weeks 1 through 4: 2 mg once weekly (subcutaneous) Weeks 5 through 8: 4 mg once weekly Weeks 9 through 12: 8 mg once weekly Week 13 and beyond: 12 mg once weekly (maintenance dose) For the 8 mg target dose, the schedule was: Weeks 1 through 4: 2 mg once weekly Weeks 5 through 8: 4 mg once weekly Week 9 and beyond: 8 mg once weekly (maintenance dose) These titration schedules are not suggestions
Those with Pre-existing CKD: If your kidney function is already significantly reduced, your reserve for handling a bout of dehydration is lower
doi:10.1038/s41523-017-0040-8 Chlebowski RT, Blackburn GL, Thomson CA, et al
Private and employer-sponsored plans: These tend to vary the most